Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis

NCT05706870 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: GN-037
DRUG: Clobetasol 17-propionate
DRUG: Placebo

Sponsor

GEN İlaç ve Sağlık Ürünleri A.Ş.

Collaborators

[object Object]